N-glycolylneuraminic acid serum biomarker levels are elevated in breast cancer patients at all stages of disease.
Lucy K Shewell,
Christopher J. Day,
Jamie R Kutasovic,
Jodie L Abrahams,
Jodi M Saunus,
Sunil R Lakhani,
Mark von Itzstein,
James C. Paton,
Adrienne W Paton,
Michael Paul Jennings
Posted 21 Jun 2021
bioRxiv DOI: 10.1101/2021.06.21.449179
Posted 21 Jun 2021
N-glycolylneuraminic acid (Neu5Gc) is an aberrant glycosylation that has been proposed as a cancer biomarker. Using a Neu5Gc-specific lectin called SubB2M in a Surface Plasmon Resonance (SPR)-based assay, we previously reported elevated Neu5Gc biomarkers in serum from ovarian cancer patients. Here we report an optimized SubB2M SPR-based assay to enhance specificity with a non-sialic acid binding version of SubB2M, SubBA12, to control for any non-specific binding to SubB2M, which improved discrimination of cancer-free controls from early-stage ovarian cancer. Using this new assay, sera from breast cancer cases were analysed, revealing significantly elevated levels of Neu5Gc biomarkers at all stages of breast cancer. We show that Neu5Gc serum biomarker levels can discriminate breast cancer patients from cancer-free individuals with high sensitivity and specificity. Analysis of serum collected prospectively, post-diagnosis, from breast cancer patients at high risk for disease recurrence showed a trend for a decrease in Neu5Gc levels immediately following treatment for those in remission. Neu5Gc serum biomarkers are a promising new tool for early detection and disease monitoring for breast cancer that may complement current imaging- and biopsy-based approaches.
- Downloaded 424 times
- Download rankings, all-time:
- Site-wide: 90,776
- In cancer biology: 2,702
- Year to date:
- Site-wide: 20,933
- Since beginning of last month:
- Site-wide: 24,156
Downloads over time
Distribution of downloads per paper, site-wide
- 27 Nov 2020: The website and API now include results pulled from medRxiv as well as bioRxiv.
- 18 Dec 2019: We're pleased to announce PanLingua, a new tool that enables you to search for machine-translated bioRxiv preprints using more than 100 different languages.
- 21 May 2019: PLOS Biology has published a community page about Rxivist.org and its design.
- 10 May 2019: The paper analyzing the Rxivist dataset has been published at eLife.
- 1 Mar 2019: We now have summary statistics about bioRxiv downloads and submissions.
- 8 Feb 2019: Data from Altmetric is now available on the Rxivist details page for every preprint. Look for the "donut" under the download metrics.
- 30 Jan 2019: preLights has featured the Rxivist preprint and written about our findings.
- 22 Jan 2019: Nature just published an article about Rxivist and our data.
- 13 Jan 2019: The Rxivist preprint is live!